BioAge Labs, Inc.

BIOA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001709941

SEC filings (opens in a new tab)

No open-market purchases or sales by BioAge Labs, Inc. insiders were filed in the last 90 days; 150 institutions reported holding it in 13F filings for Q2 2026, worth $924.6M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding BioAge Labs, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of BIOA: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	144	3	150	+9
Shares	34.3M	2.10M	37.7M	+5.54M (+17.2%)
Value	$599.2M	$36.7M	$924.6M	+$362.1M (+64.4%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held BioAge Labs, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to BIOA in Q2 2026
Institution	Shares	Value	% of portfolio
Jupiter Topco LLC	2,144,633	$52.6M	0.02%
MPM Oncology Impact Management LP	1,667,661	$40.9M	2.49%
Integral Health Asset Management, LLC	300,000	$7.35M	0.30%
Ikarian Capital, LLC	200,000	$4.90M	0.80%
Yiheng Capital Management, L.P.	170,532	$4.18M	1.84%
Squadron Capital Management LLC	155,000	$3.80M	1.30%
NEXTBio Capital Management LP	100,732	$2.47M	1.14%
Citadel Advisors LLC	78,365	$1.92M	0.00%
Birchview Capital, LP	69,000	$1.69M	0.79%
Boothbay Fund Management, LLC	61,380	$1.50M	0.03%
Moody Aldrich Partners LLC	47,491	$1.16M	0.21%
Jane Street Group, LLC	24,089	$590.4K	0.00%
Caption Management, LLC	23,240	$569.6K	0.02%
Man Group plc	18,147	$444.8K	0.00%
Virtus Investment Advisers, Inc.	18,137	$444.5K	0.10%
Engineers Gate Manager LP	14,015	$343.5K	0.00%
Glenmede Trust Co NA	10,960	$268.6K	0.00%
Profund Advisors LLC	10,880	$266.7K	0.01%
Manufacturers Life Insurance Company, The	9,529	$233.6K	0.00%
Quadrature Capital Ltd	9,480	$232.4K	0.00%
Adviser Investments LLC	9,091	$222.8K	0.00%
State of Wyoming	6,274	$153.8K	0.02%
Royal Bank of Canada	1,070	$26.0K	0.00%
SRS Capital Advisors, Inc.	542	$13.3K	0.00%
Truvestments Capital LLC	119	$2.92K	0.00%
Silver Grove Financial Group, Inc.	15	$368	0.00%
Fifth Third Bancorp	11	$270	0.00%
SBI Securities Co., Ltd.	4	$98	0.00%

Sold out (19)

Institutions that held BioAge Labs, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of BIOA in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
ADAR1 Capital Management, LLC	135,560	$2.37M
Alyeska Investment Group, L.P.	75,000	$1.31M
Algert Global LLC	64,226	$1.12M
SEI Investments Co	62,385	$1.09M
Trexquant Investment LP	60,572	$1.06M
EAM Investors, LLC	34,809	$608.8K
Jump Financial, LLC	33,900	$592.9K
Los Angeles Capital Management LLC	33,899	$592.9K
Polymer Capital Management (US) LLC	11,688	$204.4K
Winton Group Ltd	10,165	$177.8K
Fox Run Management, L.L.C.	10,850	$171.8K
Antipodes Partners Ltd	915	$16.0K
Aquatic Capital Management LLC	881	$15.4K
Meeder Asset Management Inc	631	$11.0K
Caitong International Asset Management Co., Ltd	208	$3.64K
Advisory Services Network, LLC	53	$927
Fortitude Family Office, LLC	27	$472
Sunrise Financial Services, LLC	26	$455
MAI Capital Management	6	$105

Not filed for Q2 2026 yet (3)

Institutions that held BioAge Labs, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BIOA in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Janus Henderson Group PLC	2,094,270	$36.6M
CWM, LLC	3,678	$64.3K
Sunbelt Securities, Inc.	3	$52